Apixaban in DVT, pulmonary embolism: Patients with high BMI benefit considerably

5 diciembre 2014

There is proof of an added benefit of initial treatment with the new drug in a BMI over 28 kg/m2, but not in lower BMI and for long-term prevention, research indicates.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/6w0qcYjGV6Y/141205114001.htm